Researchers believe 'magic' mushrooms have the potential to curb obesity
- Psychedelic drug researchers believe
psilocybinin "magic" mushrooms could help curb obesitycaused by overeating.
- Psilocybin has been shown to cause brain-level changes that help people shift their mindset and habits.
- Existing research suggests psilocybin can help people overcome anxiety and depression.
Already, a mounting body of research from scientists at Johns Hopkins and New York University suggests the drug can help with anxiety and depression when traditional antidepressant medications don't work.
Now, Dr. C. Laird Birmingham, an eating disorder specialist and epidemiologist, is working with psychedelics research startup NeonMind to design a study that examines whether the trippy drug could be effective for weight-loss purposes.
The study, which will take place at the University of British Columbia, is still in its design phase, but Birmingham said previous psilocybin research suggests it's promising.
"Psilocybin has the potential to serve as a new and different tool to help people lose weight and maintain their
Using psilocybin to target the roots of obesity
In some cases, obesity can be attributed to overeating, especially in the US where it's considered an epidemic.
Certain diseases like polycystic ovarian syndrome and Cushing's disease may also contribute to weight gain, and antidepressant medications and food insecurity have also been shown to contribute. In those cases, using psychedelic
But the drug could potentially help with all kinds of behavior- and addiction-related maladies, including overeating and under-eating, according to Matthew Johnson, a Johns Hopkins researcher who has published various studies on psilocybin 's mental-health benefits.
His team is in the process of completing their own study on how psilocybin could help people with anorexia nervosa, an eating disorder that affects about 328,200 adults in the US.
"There's a very good case to be made that the long-term effects that we see with psychedelics are more akin to the long term effects we see from psychotherapy," Johnson told Insider.
He said that people who have had psilocybin trips in clinical settings appear to learn something from those experiences, which change their thinking for the long-term, much like therapy can.
Of course, psilocybin isn't the perfect answer. A subset of the population could respond poorly to psychedelics if they have a history of psychotic disorders, and a bad trip that dissuades a user from ever trying the drug again is a possibility, said Johnson.
That's why he only advocates for clinical trials, which require in-depth pre-screenings and follow-up sessions.
- RBI extends deadline to exchange, deposit Rs 2,000 notes till Oct 7
- Explained: TCS on your child's overseas education and mitigating strategies
- From Pixel 8 to Galaxy S23 FE – smartphones launching in October 2023
- World Cup 2023 final squads – Ind, Aus, Eng and all the other teams
- Eating your way to clear vision: 10 foods for healthy eyes